Based on interview and record review, the facility failed to limit an as needed anti-anxiety medication order to 14 days or provide a physician's rationale for continued extension of the medication's use, for 1 (#20) of 17 sampled residents. Findings include: Review of resident #20's physician's orders, dated 11/21/24 to 4/23/25, showed an order for Lorazepam oral concentrate 2 MG/ML. Give 0.25 ml by mouth every 8 hours as needed for anxiety. No stop date noted on the orders. Review of physician's progress notes dated 12/18/24, 2/11/25, and 4/15/25, showed no documentation for the continued use of lorazepam past 14 days. During an interview on 4/24/25 at 9:01 a.m., staff member L stated, Psychotropic medications are frowned upon and should be minimized. …
F758 citations in Montana
Psychotropic drugs · Pharmacy Service Deficiencies
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Montana cites F758 less often than its own record predicts
0.99 times the national share — cited less often here than elsewhere.
Of every deficiency written in Montana in 2025, this is the portion that was F758.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Montana surveyors wrote
F758 findings written in Montana, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
The short window
Recent years
| Year | Share of Montana citations | vs expected |
|---|---|---|
| 2023 | 1.98% | 1.20× |
| 2024 | 2.62% | 1.76× |
| 2025 | 0.63% | 0.99× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else Montana surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction